Predictive Oncology Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
25 Sep 23 | SellUS$30,387 | Charles Nuzum | Individual | 10,000 | US$3.04 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Private Companies | 208,186 | 5.08% |
Individual Insiders | 258,136 | 6.29% |
Institutions | 295,979 | 7.22% |
General Public | 3,339,703 | 81.4% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 2.4%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
205,501 | US$322.5k | 0% | no data | |||
143,518 | US$225.3k | 2.07% | no data | |||
120,807 | US$189.6k | 0.01% | no data | |||
104,585 | US$164.1k | 0% | no data | |||
37,583 | US$59.0k | 0.3% | no data | |||
31,921 | US$50.1k | 19.8% | no data | |||
22,534 | US$35.4k | 25.7% | no data | |||
21,237 | US$33.3k | 25.2% | no data | |||
20,835 | US$32.7k | 0% | no data | |||
18,661 | US$29.3k | 27.3% | no data | |||
17,176 | US$27.0k | 21.2% | no data | |||
13,837 | US$21.7k | -17.8% | no data | |||
10,358 | US$16.3k | 0% | 0.03% | |||
9,488 | US$14.9k | 33% | no data | |||
9,117 | US$14.3k | 55.9% | no data | |||
7,122 | US$11.2k | 0% | no data | |||
5,451 | US$8.6k | 0% | no data | |||
4,816 | US$7.6k | 0% | no data | |||
2,685 | US$4.2k | 12.3% | no data | |||
2,369 | US$3.7k | 0% | no data | |||
1,263 | US$2.0k | -50.6% | no data | |||
425 | US$667.0 | 0% | no data | |||
399 | US$626.4 | 0% | no data | |||
100 | US$157.1 | 0% | no data | |||
95 | US$149.4 | 0% | no data |